OTC · APYP
Technology · Software - Application
$0.01
Down-$0.00 (-7.12%)
Updated Sep 12, 2026, 5:12 PM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
APYP does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning APYP.
APYP research
Company profile and research snapshot.
APPYEA INC
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Nov 18, 2025
AppYea Inc. is pursuing strategic initiatives including potential uplisting to a national exchange, rebranding to Mellatrix, and integrating Techlott blockchain infrastructure while exploring entry into prediction markets.
Yahoo · Nov 18, 2025
AppYea, Inc. (OTCQB: APYP) today announced the acceleration of its strategic internal management review toward a potential uplisting to a U.S. national securities exchange (Nasdaq or NYSE American), subject to meeting all applicable listing requirements. As of the date hereof, no listing application has been submitted to any exchange. This initiative is progressing in parallel with the Company's planned rebranding and name change to Mellatrix Inc., and the anticipated submission of applications
Benzinga · Oct 15, 2025
Appyea, Inc. introduced Techlott, a blockchain infrastructure designed to enhance transparency and trust in gaming and prediction markets, with a focus on B2G/B2B deployments and potential future token issuance.
Benzinga · Sep 30, 2024
AppYea has launched a new wearable device called AppySleep that uses AI and biofeedback to detect and address snoring. The device connects to a mobile app and can track breathing patterns and vibrate to encourage users to change sleeping positions.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning APYP.
No results
No recent SID articles mention APYP.
